The Sur–AuNC•Gd–Cy7 nanoprobe that we have developed, which targets survivin for the purpose of diagnostic imaging of pancreatic cancer, is founded on both theoretical and experimental grounds. Here, BIRC5 is linked to pancreatic neoplasm.